ACADIA Pharmaceuticals (ACAD)
28.28
+0.64 +2.32%
NASDAQ
Jun 28, 16:59
Delayed 2m
USD
View All Key Stats
ACAD Key Stats
| Income Statement | |
| Revenue (TTM) | 32.61M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -2.61 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -309.47M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 85.20% |
| Profit Margin (Quarterly) | -574.7% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 3.451B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 102.69 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 7.544 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | -- |
| Free Cash Flow (Quarterly) | -71.15M |
| Return on Equity (TTM) | -64.26% |
View All ACAD News
ACAD News
-
WireHeadlineTime (ET)
-
Yahoo06/27 14:47
-
Yahoo06/27 08:54
-
Yahoo06/23 08:04
-
SA Breaking News06/21 11:08
-
Yahoo06/19 14:33
-
Yahoo06/16 15:19
-
Yahoo06/05 13:58
-
Yahoo06/02 09:59
-
PR Newswire05/26 09:31
-
SA Breaking News05/15 08:52
View All Events
ACAD Events
| Date | Type | Description |
|---|---|---|
| 06/13/2017 | Misc | ACADIA Pharmaceuticals Inc Annual General Meeting in 2016 |
| 05/09/2017 17:00 EDT | Misc | ACADIA Pharmaceuticals Inc First Quarter Earnings Conference Call in 2017 |
| 05/09/2017 | Earnings | ACADIA Pharmaceuticals Inc First Quarter Earnings in 2017 Release |
| 02/28/2017 17:00 EDT | Misc | ACADIA Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2016 |
| 02/28/2017 | Earnings | ACADIA Pharmaceuticals Inc Fourth Quarter Earnings in 2016 Release |
| 11/07/2016 17:00 EST | Misc | ACADIA Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2016 |
| 11/07/2016 | Earnings | ACADIA Pharmaceuticals Inc Third Quarter Earnings in 2016 Release |
| 08/04/2016 17:00 EDT | Misc | ACADIA Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2016 |
| 08/04/2016 | Earnings | ACADIA Pharmaceuticals Inc Second Quarter Earnings in 2016 Release |
ACAD Fundamentals
Income Statement View Statement
ACAD Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
ACAD One Page Reports
- One Page Report Download
ACAD Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 28.28 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.acadia-pharm.com
- Investor Relations URL: http://ir.acadia-pharm.com/phoenix.zhtml?c=125180&p=irol-irhome
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: May. 09, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: ACADIA Pharmaceuticals Inc is a biotechnology company which develops and commercializes biopharmaceutical products to address central nervous system disorders. It aims to discover small molecule drugs to address Parkinson’s, Alzheimer’s and schizophrenia.
ACAD Comparables
EditACAD Excel Add-In Codes
- Name: =YCI("ACAD","name")
- Description: =YCI("ACAD","description")
- Sector: =YCI("ACAD","sector")
- Industry: =YCI("ACAD","industry")
- Est. Current Fiscal Year End: =YCI("ACAD","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other ACAD Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ACAD Tweets Stocktwits
Advertisement
